Literature DB >> 29764354

Impact of ethnicity on the natural history of Parkinson disease.

Anna Sauerbier1, Azman Aris2, Ee Wei Lim2, Kalyan Bhattacharya3, K Ray Chaudhuri2.   

Abstract

Parkinson disease (PD) affects people of all races and ethnicity worldwide. PD is a multineurotransmitter and multisystem disorder and our current concept of the natural history of PD has changed considerably over the past decades. Many aspects of this heterogeneous condition still remain unexplained; one aspect that is poorly studied is the role of ethnicity and manifest motor and non-motor PD. Some preliminary data suggest that the prodromal risk of developing PD, clinical symptom expression and the experience of living with the condition may vary between different ethnic groups. Several factors might play a role in the influence of ethnicity on PD, such as pharmacogenetics, sociocultural aspects and environmental exposures. Increased knowledge on the role of ethnicity in PD may help shed light on the symptom expression and treatment response of PD, address inequalities in health care delivery worldwide and improve the delivery of personalised medicine.

Entities:  

Keywords:  Ethnic groups; Parkinson disease

Mesh:

Year:  2018        PMID: 29764354

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  7 in total

1.  Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Elaine Bandeira Cavalcanti Duarte; Laura Maria Ramos Miranda; Andore Guescel C Asano; Nadja Maria Jorge Asano; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Neuromolecular Med       Date:  2019-05-22       Impact factor: 3.843

2.  Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Isaura Isabelle Fonseca Gomes da Silva; Amdore Guescel C Asano; Nadja Maria Jorge Asano; Maria De Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2020-11-05       Impact factor: 2.316

3.  Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's disease.

Authors:  Nicola du Toit; Riaan van Coller; David G Anderson; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2019-09-06       Impact factor: 2.660

Review 4.  Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues.

Authors:  Kristina Hug
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

5.  Probing the Pre-diagnostic Phase of Parkinson's Disease in Population-Based Studies.

Authors:  Lisanne J Dommershuijsen; Agnita J W Boon; M Kamran Ikram
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

6.  Parkinson's Disease in Kazakhstan: Clinico-Demographic Description of a Large Cohort.

Authors:  Rauan Kaiyrzhanov; Nazira Zharkinbekova; Chingiz Shashkin; Talgat Khaibullin; Gulnaz Kaishibayeva; Vadim Akhmetzhanov; Dinara Z Sadykova; Zhanar Seidinova; Anjela Taskinbayeva; Altynay Karimova; Mie Rizig; Henry Houlden
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

7.  Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease.

Authors:  Claudia Marisol Sánchez-Martínez; José Alberto Choreño-Parra; Noel Placencia-Álvarez; Lilia Nuñez-Orozco; Parménides Guadarrama-Ortiz
Journal:  Front Neurol       Date:  2019-11-14       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.